QIAGEN N.V. Expands AI Bioinformatics With New Platforms
QIAGEN N.V. announced AI additions to Ingenuity Pathway Analysis via IPA Investigator and launched the QIAGEN Discovery Platform to extend AI into automated drug discovery workflows.
QIAGEN N.V. announced AI additions to Ingenuity Pathway Analysis via IPA Investigator and launched the QIAGEN Discovery Platform to extend AI into automated drug discovery workflows.